Sandoz VP-Biopharma Development Ajaz Hussain: An Interview With “The Pink Sheet” DAILY

In the wake of Omnitrope’s approval in the U.S. and Europe, Sandoz is moving forward with a robust biosimilar pipeline.

More from Archive

More from Pink Sheet